Raymond James & Associates’s BlackRock Health Sciences Term Trust BMEZ Stock Holding History
Bought
Maintained
Sold
Other funds holding BMEZ
Raymond James & Associates's BMEZ Position: Q3 2024 in Review
Raymond James & Associates increased its BlackRock Health Sciences Term Trust (BMEZ) stake by 0.02% in Q3 2024, buying an estimated $1.94K and bringing the position to 508,606 shares worth $8.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1351.
Raymond James & Associates first reported a position in BMEZ in Q1 2020 and has held it in 19 quarters since. The position peaked at $25.5M in Q2 2021. 92 funds tracked by Wall St. Rank hold BMEZ as of Q3 2024.
- Raymond James & Associates held 508,606 shares of BlackRock Health Sciences Term Trust worth $8.06M as of Q3 2024.
- Raymond James & Associates bought 123 BlackRock Health Sciences Term Trust shares in Q3 2024, an estimated $1.94K.
- BlackRock Health Sciences Term Trust made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1351 holding.
- Raymond James & Associates first reported a position in BlackRock Health Sciences Term Trust in Q1 2020 and has held it in 19 quarters since.
- Raymond James & Associates's BlackRock Health Sciences Term Trust position peaked at $25.5M in Q2 2021.
- 92 funds tracked by Wall St. Rank held BlackRock Health Sciences Term Trust as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.